Elon Musk Has Used Illegal Drugs, Worrying Leaders at Tesla and SpaceX
Some executives and board members fear the billionaire’s use of drugs—including LSD, cocaine, ecstasy, mushrooms and ketamine—could harm his companies....
Pharmaceuticals
Bayer Told to Pay $1.56 Billion After Losing Roundup Case
Updated Nov. 18, 2023 7:43 pm ETBayer faces a payout of $1.56 billion after a Missouri jury found in favor...
Wegovy Maker Novo Nordisk to Spend $6 Billion Boosting Production Capacity
Novo Nordisk, the Danish pharmaceutical giant that makes the blockbuster Wegovy obesity drug, said it will invest more than $6...
Why Your Neighborhood Pharmacy Isn’t So Friendly Anymore
CVS and Walgreens pharmacy employees say they are overworked, understaffed, and more liable to make prescription errors due to the...
Roche to Buy Bowel-Disease Drug From Roivant, Pfizer for More Than $7 Billion
Updated Oct. 23, 2023 6:55 am ETRoche Holding has agreed to buy the developer of a bowel-disease treatment from Roivant...
WSJ News Exclusive | CVS Pulls Certain Cold Medicines From Shelves and Will Stop Selling Them
Updated Oct. 20, 2023 11:00 am ETCVS Health is pulling some of the most common decongestants from its shelves and...
New Playground, New Court, New Classroom? Thank Ozempic.
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber...
Pharmacy Giant Walgreens Names Tim Wentworth as New CEO
The incoming chief executive faces a tough challenge, with a core business under pressure due to pharmacy-benefit managers such as...
Bristol Myers Squibb to Acquire Mirati Therapeutics in Deal Worth Up to $5.8 Billion
The deal expands the pharmaceutical company’s portfolio of cancer drugs. Source link
The Company That Defined Dieting Is Sorry It Told Us to Have More Willpower
Ozempic, Oprah and apologies: WeightWatchers says there’s no shame in being overweight, or in taking new weight-loss drugs. Source link
J&J’s $40 Billion Split-Off Sets Stage for Pharma, Medical Tech Expansion
The healthcare giant’s separation of its consumer-health business arms it with billions in cash for allocating capital in the remaining...
Amgen’s $27.8 Billion Deal for Horizon Therapeutics Clears Key Hurdle
The Federal Trade Commission said it had agreed to end its legal challenge of the $27.8 billion deal. The pact...
FTC Pauses Challenge to Amgen’s $27.8 Billion Deal for Horizon Therapeutics
The move gives the agency time to weigh a settlement that would allow the deal to close with conditions. Source...
Teva Agrees to Pay $225 Million to Settle U.S. Price-Fixing Charges
The generic drugmaker’s U.S. unit also must sell the drug line for cholesterol treatment pravastatin. Source link
Weight-Loss Drug Wegovy Cuts Heart Attack, Stroke Risk by 20% in New Study
Novo Nordisk’s anti-obesity drug reduced people’s risk of suffering heart attacks, strokes and cardiovascular deaths by 20%. Source link
First Pill for Postpartum Depression Is Approved by FDA
The pill, to be taken daily for at least two weeks, significantly reduced postpartum depression among new mothers in a...
CVS to Shed 5,000 Jobs in Cost-Cutting Push
The healthcare giant wants to trim corporate roles and spending on travel and its use of consultants. Source link
Biogen Buying Rare-Disease Drugmaker in $7.3 Billion Deal
The deal would bolster the biotech company’s portfolio of treatments for neuromuscular and rare diseases. Source link
Eli Lilly to Acquire Obesity-Treatment Maker Versanis
Versanis shareholders could receive as much as $1.925 billion in cash, in an upfront payment and additional payments if certain...
FDA Approves Leqembi, Extending Alzheimer’s Treatment to More Patients
Medicare enrollees can get the anti-amyloid treatment as a result of the agency’s full approval. Source link
